Roselabs Finance Limited Board Meeting held on April 16, 2026 approving appointment of statutory and secretarial auditors under Regulation 30

2 min read     Updated on 16 Apr 2026, 08:06 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Roselabs Finance Limited announced auditor appointments at its April 16, 2026 board meeting, appointing Walker Chandioke & Co., LLP as statutory auditors for five consecutive years and Shravan A. Gupta & Associates as secretarial auditors for FY 2026-27, both subject to shareholder approval.

powered bylight_fuzz_icon
37895293

*this image is generated using AI for illustrative purposes only.

Roselabs Finance Limited announced significant auditor appointments following its board meeting held on April 16, 2026. The company's board of directors approved the appointment of new statutory and secretarial auditors in compliance with Regulation 30 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations, 2015. The board meeting commenced at 5:30 p.m. IST and concluded at 5:55 p.m. IST.

Statutory Auditor Transition

The board approved the appointment of M/s Walker Chandioke & Co., LLP as the company's new statutory auditors. This appointment comes as the current statutory auditors, M/s MSKA & Associates LLP, will complete their second consecutive term of five years and retire at the forthcoming 32nd Annual General Meeting.

Parameter: Details
New Statutory Auditor: M/s Walker Chandioke & Co., LLP
Firm Registration No.: 001076N/N500013
Term Duration: 5 consecutive years
Effective Period: FY 2026-27 to conclusion of 37th AGM
Approval Required: Shareholders at ensuing AGM

The appointment was recommended by the Audit Committee and subsequently approved by the board. Walker Chandioke & Co., LLP is a chartered accountants firm registered with the Institute of Chartered Accountants of India, Public Company Accounting Oversight Board, and empaneled with Comptroller and Auditor General of India. Established in 1935, the firm operates from its registered office in New Delhi with eighteen other offices across major Indian cities and has eighty-six partners. The firm holds a valid peer review certificate and is recognized as one of India's leading audit firms, providing audit and assurance services to several large companies including some of the top one hundred listed entities in India.

Secretarial Auditor Appointment

The board also approved the appointment of M/s Shravan A. Gupta & Associates as the secretarial auditors for the financial year 2026-27. The firm is described as a peer-reviewed company secretaries firm providing comprehensive corporate secretarial and corporate services.

Parameter: Details
Secretarial Auditor: M/s Shravan A. Gupta & Associates
Appointment Period: Financial Year 2026-27
Experience: Over 12.50 years
Specialization: Corporate laws, securities laws, capital market
Services: Corporate governance advisory

The firm has extensive experience in diverse areas including corporate laws, securities laws, capital market operations, and corporate governance. They serve as chief advisors to boards of directors on best practices in corporate governance within the rapidly changing regulatory and corporate environment.

Regulatory Compliance and Disclosure

The company has fulfilled its disclosure obligations under Regulation 30 of the Listing Regulations by informing BSE Limited and uploading the information on its website at www.roselabsfinancelimited.in . The communication was signed by Gunjan Taunk, Company Secretary and Compliance Officer (Membership No. A23346), and digitally signed on April 16, 2026.

Compliance Parameter: Details
BSE Scrip Code: 531324
Regulation: SEBI Listing Regulations 30
Website Upload: www.roselabsfinancelimited.in
Digital Signature Date: April 16, 2026 19:35:36 +05'30'

Both auditor appointments are subject to shareholder approval at the upcoming Annual General Meeting. The transition represents a routine change in statutory auditors following the completion of the maximum permissible tenure, while the secretarial auditor appointment ensures continued compliance with regulatory requirements for the upcoming financial year.

Historical Stock Returns for Roselabs Finance

1 Day5 Days1 Month6 Months1 Year5 Years
+4.46%-4.26%+7.66%-31.26%-27.42%-29.13%

What factors led to Roselabs Finance choosing Walker Chandioke & Co. over other potential statutory auditors for the next five-year term?

How might the transition to new auditors impact Roselabs Finance's audit fees and overall compliance costs for FY 2026-27?

Will the new auditor appointments signal any changes in Roselabs Finance's financial reporting practices or accounting policies?

Roselabs Finance Q3FY26 Results: Loss Narrows to ₹3.67 Crores, Revenue Reaches ₹120.75 Crores

2 min read     Updated on 20 Jan 2026, 06:23 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Roselabs Finance Limited reported improved Q3FY26 results with net loss narrowing to ₹3.67 crores from ₹10.84 crores in Q3FY25, while generating revenue of ₹120.75 crores. Nine-month performance showed net loss reduction to ₹14.33 crores from ₹24.63 crores year-on-year. The company's proposed merger with Lodha Developers Limited received BSE approval, with NCLT filing in progress.

powered bylight_fuzz_icon
30459183

*this image is generated using AI for illustrative purposes only.

Roselabs Finance Limited has announced its unaudited financial results for the quarter ended December 31, 2025, showing improved performance with a narrowed net loss despite operational challenges. The Board of Directors approved these results at a meeting held on January 20, 2026, with statutory auditors MSKA & Associates LLP providing an unmodified opinion on the financial statements.

Financial Performance Overview

The company's financial performance for Q3FY26 demonstrated significant improvement compared to the corresponding quarter of the previous year:

Financial Metric: Q3FY26 Q3FY25 Change
Revenue from Operations: ₹120.75 cr ₹0.00 cr New Revenue
Total Income: ₹120.75 cr ₹0.34 cr Substantial increase
Net Loss: ₹3.67 cr ₹10.84 cr 66.14% improvement
Earnings Per Share: ₹(0.04) ₹(0.11) Improved

Nine-Month Performance Analysis

For the nine months ended December 31, 2025, Roselabs Finance showed considerable improvement in its financial position:

Nine-Month Metrics: FY26 (9M) FY25 (9M) Performance
Revenue from Operations: ₹120.75 cr ₹0.00 cr New revenue stream
Total Income: ₹120.75 cr ₹1.68 cr Significant growth
Net Loss: ₹14.33 cr ₹24.63 cr 41.82% reduction
EPS (9 months): ₹(0.14) ₹(0.25) Improved

Expense Structure and Cost Management

The company's expense breakdown for Q3FY26 reveals the operational structure of its real estate development business. Cost of projects constituted the largest expense component at ₹119.55 crores, directly correlating with the revenue generation. Employee benefits expenses remained controlled at ₹1.25 crores, while other expenses totaled ₹3.62 crores, showing improved cost management compared to ₹9.89 crores in Q3FY25.

Corporate Developments

Roselabs Finance operates exclusively in the real estate development segment with operations confined to India. The company has no subsidiaries, joint ventures, or associate companies, eliminating the need for consolidated financial statements. A significant corporate development involves the proposed merger with Lodha Developers Limited (formerly Macrotech Developers Limited), which received BSE approval on December 30, 2025. The company is currently in the process of filing the merger application with the NCLT Mumbai Bench.

Capital Structure and Shareholding

The company maintains a stable capital structure with paid-up equity share capital of ₹1,000.00 crores, consisting of shares with a face value of ₹10 each. This capital base has remained unchanged across all reported periods, providing stability for the company's operations and strategic initiatives.

Regulatory Compliance and Audit Opinion

The financial results were prepared in accordance with Indian Accounting Standard 34 for Interim Financial Reporting and comply with SEBI Listing Regulations. The statutory auditors conducted their review in accordance with Standard on Review Engagement (SRE) 2410 and expressed an unmodified conclusion, indicating no material concerns with the financial statements' preparation and presentation.

Historical Stock Returns for Roselabs Finance

1 Day5 Days1 Month6 Months1 Year5 Years
+4.46%-4.26%+7.66%-31.26%-27.42%-29.13%

More News on Roselabs Finance

1 Year Returns:-27.42%